Counterpoint Quantitative Equity ETF
CPAINYSECounterpointEquity
As of Oct 23, 2026 close
- Assets (AUM)
- $468.33M
- Expense ratio
- 0.75%
- Dividend yield
- 0.68%
- Holdings
- 51
- 52-week range
- $37.29$53.96
- Volume (live)
- -
- Avg. volume (3M)
- 78.17K
CPAI ETF: Counterpoint Quantitative Equity ETF - Price, Holdings & Analysis
Counterpoint Quantitative Equity ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $52.45 - $52.95 |
|---|---|
| 52-Week High | $53.96 |
| 52-Week Low | $37.29 |
| Open | $52.69 |
| Volume (last close) | 77.34K |
| Average Volume (3M) | 78.17K |
| 1 Day Change | −0.90% |
|---|---|
| 1 Month Change | +0.94% |
| 6 Month Change | +14.43% |
| YTD Change | +30.15% |
| 1 Year Change | +32.85% |
| Annual Dividend | $0.36 |
|---|---|
| Dividend Yield | 0.68% |
| Last Dividend Ex-Date | Dec 12, 2025 |
| Dividend Growth YoY | +154.23% |
| Years Dividend Growth | 2 |
| Assets (AUM) | $468.33M |
|---|---|
| Expense Ratio | 0.75% |
| Total Holdings | 51 |
| Inception Date | Nov 27, 2023 |
| 50-Day MA | $52.40 |
|---|---|
| 200-Day MA | $48.01 |
| RSI | 54.71 |
| Stochastic %K | 65.65 |
| Stochastic %D | 44.53 |
Source: Exchange price data and fund disclosures. Data as of Oct 23, 2026. Data sources and methodology
CPAI at a Glance
Counterpoint Quantitative Equity ETF (CPAI) is an equity ETF from Counterpoint, launched in November 2023. It manages $468.33M in assets and charges a 0.75% expense ratio, about $75 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 51 positions. The largest are 10x Genomics, Inc (TXG, 3.44%), PBF Energy Inc (PBF, 3.30%) and AbCellera Biologics Inc (ABCL, 2.96%). The top 10 holdings make up 27.7% of the fund. By sector it leans toward Technology (36.6%), Energy (19.5%) and Healthcare (14.1%). Its largest country exposures are United States (80.4%), Israel (6.2%) and United Kingdom (5.2%).
It pays distributions yielding 0.68% at the Oct 23, 2026 close, $0.36 per share over the trailing 12 months. As of the Oct 23, 2026 close, the share price is up 32.9% over one year (price change, excluding distributions).
Frequently Asked Questions About Counterpoint Quantitative Equity ETF
What is the current price of CPAI?
The latest CPAI price is $52.54 (Oct 23, 2026 close). The 52-week range is $37.29–$53.96. The share price is up 32.9% over the past year (price change, excluding distributions).
What is the expense ratio for CPAI?
CPAI's annual expense ratio is 0.75%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does CPAI pay dividends?
Yes, CPAI pays a 0.68% dividend yield (trailing 12 months, at the Oct 23, 2026 close). The most recent ex-dividend date was December 12, 2025. View full dividend history in the Dividends section.
What are the top holdings of CPAI?
As of Oct 4, 2026, CPAI's largest holdings are 10x Genomics, Inc (3.4%), PBF Energy Inc (3.3%), AbCellera Biologics Inc (3.0%) (combined weight: 9.7%). The fund holds 51 total positions. View the complete portfolio breakdown in the Holdings section.
How does CPAI compare to similar ETFs?
Compare CPAI (0.75% expense ratio, $468M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.